<?xml version="1.0" encoding="UTF-8"?>
<ref id="B229">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tsybalova</surname>
    <given-names>L. M.</given-names>
   </name>
   <name>
    <surname>Stepanova</surname>
    <given-names>L. A.</given-names>
   </name>
   <name>
    <surname>Kuprianov</surname>
    <given-names>V. V.</given-names>
   </name>
   <name>
    <surname>Blokhina</surname>
    <given-names>E. A.</given-names>
   </name>
   <name>
    <surname>Potapchuk</surname>
    <given-names>M. V.</given-names>
   </name>
   <name>
    <surname>Korotkov</surname>
    <given-names>A. V.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2015</year>). 
  <article-title>Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: broad protective efficacy of particles carrying four copies of M2e</article-title>. 
  <source>Vaccine</source>
  <volume>33</volume>, 
  <fpage>3398</fpage>â€“
  <lpage>3406</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.04.073</pub-id>
  <?supplied-pmid 25976545?>
  <pub-id pub-id-type="pmid">25976545</pub-id>
 </mixed-citation>
</ref>
